"I had filler before — do I need to mention it?"
Many people hit this question while researching Ulthera or Thermage. The procedure may have been years ago, memory is fuzzy, and it is easy to wonder whether mentioning it still matters.
You should mention it. Where previously placed material may still remain, the plan for an energy-based approach can change. That does not mean "it is dangerous, so do not do it." It means the history becomes judgment material for adjusting areas and sequence. Combination procedures involving fillers, toxins, and energy devices have been addressed in international consensus literature. Cellinique Clinic — a 10-minute walk from Apgujeong Station, at 228 Dosan-daero — summarizes what we confirm in consultation.
3-line summary
1. Write prior procedures as what · when · where · how you responded afterward — four items. A document is more accurate than memory.
2. Combination of fillers, toxins, and ultrasound devices is an area reviewed in international consensus literature. You can ask about that evidence in consultation.
3. The purpose of sharing history is not to block a procedure, but to adjust areas and sequence.
1. Write your history in four items
| Item | Be specific about | Why it matters |
|---|---|---|
| What | Product name or ingredient (HA · CaHA · PLLA · toxin) | Materials differ in properties |
| When | Timing even if only by month | Helps judge whether material may remain |
| Where | Forehead · temples · mid-cheek · nasolabial folds · jawline, etc. | Whether it overlaps the energy application range |
| Response afterward | Swelling · bruising · nodules · asymmetry, etc. | Judgment material for this plan |
If you had threads or other lifting implants, write those in the same format. If you do not remember the product name, bringing the handout or consent copy from that visit is the most accurate option.
Even partial notes help. Product family without a brand name, a year-level date, or "left cheek only" is still usable. What blocks planning is not incomplete recall — it is history that never reaches the consultation at all.
2. Why the energy plan may change
Ulthera delivers ultrasound, and Thermage delivers radiofrequency — both are approaches that transmit thermal energy into tissue. If previously placed material may still sit inside that range, application method, intensity, and area layout may be adjusted.
Fact check — evidence level: international expert consensus
A global aesthetic consensus on combination of hyaluronic acid fillers and type A botulinum toxin, and a pan-Asian consensus on combination of fillers, toxins, and ultrasound devices, have each been published. Combination procedures are an area addressed by expert consensus.
Consensus documents cover general principles; an individual plan still depends on prior material, area, timing, and current status. (Sources: PubMed 27119917, 28979659)
So the three questions to ask in consultation are: how you approach areas that still hold prior material, how you lay out the application range, and whether sequencing as separate steps is better.
These three questions turn a vague "is it okay?" into a plan you can act on. Ask them after you place your four-item history on the table — sequence first, intensity second, and range third — so the conversation stays concrete rather than abstract.
3. Separating the sequence is an option
Having history does not usually mean you cannot have a procedure. Far more often, the outcome is adjusting the sequence. So it is normal when consultation ends with "this first now, that next time."
Separating the sequence improves two things. First, you can tell which result came from which step. When several things run at once, it is hard to judge what played which role. Second, response handling becomes clearer if a reaction appears. Proceeding one approach at a time shows which step it came from.
If you were also guided on a combined plan, see our combined procedure sequence guide as well.
Sequence separation is not a demotion of your plan. It is often the safer way to keep both goals — energy work and prior injectable history — under control without guessing which variable changed the face.
4. What to confirm for toxin history
Botulinum toxin differs in character from fillers, so the confirmation items differ too. Tell us the last procedure timing, the areas, and whether you still feel residual effect now.
This information matters because when toxin-active areas and energy approach overlap, they can affect expression and contour judgment. To assess current status in consultation, timing information is needed.
Even if the last session was months ago, say so. Residual feel is subjective, but pairing it with calendar timing still helps the clinician read expression at rest and in motion before any energy map is drawn.
5. What to confirm for filler history
For fillers, the ingredient family matters. HA (hyaluronic acid), CaHA (Radiesse family), PLLA, and similar materials differ in properties, so residual patterns differ too.
Fact check — evidence level: regulatory guidance document
In its dermal filler guidance, the U.S. FDA lists unusual pain during or right after a procedure, vision changes, and skin around the injection site turning white or appearing gray or blue as signals that need immediate medical help.
These criteria apply to fillers addressed by the U.S. FDA; other injectable materials should be checked individually against each product's materials. (Source: FDA, dermal fillers)
If you have ever experienced such signals, tell us without fail. That becomes grounds for setting areas and approach differently in this plan.
Whether areas overlap is the core question
This is why you write areas specifically when recording history. Judgment splits on whether the prior-material site and this energy application range overlap.
| Situation | Direction that often appears in consultation |
|---|---|
| Areas do not overlap | Usually proceed with the planned map |
| Areas overlap · timing is remote | Judge after assessing current status |
| Areas overlap · recent | Adjust application range or separate the sequence |
| Past abnormal reaction | Set areas and approach differently |
As the table shows, most cases are about adjustment, not about whether to proceed at all. Sharing history is not a disadvantage. If you do not share it, the chance to adjust disappears.
Bring a face map if you can — even a phone sketch labeling "temple," "nasolabial fold," or "jawline" is enough. Overlap is a spatial question; vague wording like "I had filler on my face" is less useful than one labeled zone.
6. When you cannot remember the history
Even if recall is incomplete, sharing what you know is better than silence. Something like "about three to four years ago I had filler in the nasolabial folds; I do not know the product name" is still usable for judgment.
If possible, request records from the previous clinic. Product name, timing, and volume often remain on file. Going forward, keep consent copies, handouts, and material information after every procedure so you can use them in situations like this.
Record habits for next time
The inconvenience you face now can repeat next time. Each time you have a procedure, store the following four items in one place so the next consultation is far more accurate.
Consent copy, handouts you received, confirmation details for the product used, and procedure date and areas. Photographing them into one folder is enough. When you change clinics or consult years later, these records stand in for memory.
Before-and-after photos in natural light also help. They explain change more accurately than words alone and become a baseline when the next plan is built.
7. Consultation checklist
□ Did you write prior procedures as what · when · where · response — four items
□ Did you include thread or implant history as well
□ Did you bring prior handouts or consent copies
□ For toxin, did you share last timing and residual feel now
□ For filler, did you confirm ingredient family (HA · CaHA · PLLA)
□ If you had past abnormal signals, did you share them
□ Did you ask about the approach for areas with prior material
□ Did you hear the option of separating sequence
Bring this checklist on paper or on your phone. Empty boxes are reasons to ask again before you leave — not items to reconstruct later from internet comments.
Frequently asked questions
Q1. Should I mention filler from long ago?
Yes, mentioning it is better. Residual patterns differ by material and area, and that information is used to judge areas and sequence for this plan. "It was a long time ago" is itself useful information.
Q2. If I have filler, can I not get Ulthera?
Cases where you cannot receive it are less common than cases where areas and sequence are adjusted. In consultation, ask how areas with prior material will be approached and how the application range will be laid out.
Q3. What if I do not remember the product name?
Share what you know. Timing and area alone are still used for judgment. Request records from the previous clinic, or look for the handout or consent from that visit, for more accuracy.
Q4. Why do you ask about toxin timing?
When toxin-active areas and energy approach overlap, they can affect expression and contour judgment. To assess current status accurately, last timing and residual feel are needed.
Q5. Can I have several procedures together?
Combination procedures are an area addressed in international consensus literature, but separating sequence helps you tell which result came from which step. Ask in consultation about the difference between same-day combination and staged sequencing.
Q6. If I share my history, will the procedure be refused?
Most cases lead to adjusting areas and sequence, not to a yes-or-no refusal. If you do not share history, the chance to adjust disappears. History is not information that blocks a plan — it is information that makes the plan more accurate.
Consultation information
Cellinique Clinic is at Yeonseung Building, 228 Dosan-daero, Gangnam-gu, Seoul — about a 10-minute walk from Apgujeong Station or Hakdong Station. Medical Director Dr. Kim Gun-woo handles consultation, treatment, and aftercare directly. Area and sequence adjustments based on prior history are confirmed individually in consultation. Differences between Ulthera and Thermage are in our comparison of the two procedures, and safety observation items are on the treatment safety page.
This article is general information and does not replace medical care. Diagnosis and plans suited to your condition should be confirmed in consultation.
Sources
- Global aesthetic consensus on combination of hyaluronic acid fillers and type A botulinum toxinPubMed / U.S. National Library of Medicine
- Pan-Asian consensus on combination of fillers, toxins, and ultrasound devicesPubMed / U.S. National Library of Medicine
- Dermal fillers (soft tissue fillers)U.S. Food and Drug Administration
Discuss options for your current needs
We review your current health and prior procedures before explaining appropriate options and their limits.



